Although this study focused on SFRP1 as a promising candidate for epigenetic therapy of NSCLC, 31 other proteins selected in Table 1 might also have potential for NSCLC epigenetic therapy. The gene discussed is SFRP1; the disease is non-small cell lung carcinoma.